Mark Nestor, MD, PhD, a co-director of the Winter Clinical Miami meeting, promises attendees a hands-on learning experience with real-world applicability.
Allie Karas, MA
Advertisement
Allie Karas is the vice president of content for the Health Care Specialty Group division of MJH Life Sciences. She attended Rider University and earned a degree in journalism before pursing a masters in magazine writing from New York University. Prior to making a switch to health care news in 2018, Allie spent 6 years in New York City working in political journalism. She enjoys spending time with her husband and 3 kids, cooking, working out, and her dog Bo. Follow her on Twitter at @alliewardkaras or email her at akaras@mjhlifesciences.com
Articles by Allie Karas, MA
Using pooled 52-week results from TRuE-AD1 and TRuE-AD2, investigators examined how the topical JAK1/JAK 2 inhibitor affects patient feelings of skin pain, discomfort, anxiety, and depression.
Dermoscopy is a valuable tool in differentiating regular pigmented lesions from dangerous skin cancers. At SDPA 2022, Orit Markowitz, MD, summarizes skin of color dermoscopy.
After reporting initial data earlier this year, investigators presented a fuller analysis in a poster at the 2022 SDPA Annual Fall Dermatology Conference.
The greatest improvements in quality of life measures were seen in the 300 mg tralokinumab group.
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
